Status:
COMPLETED
Effectiveness of Zinc Supplementation With Topical Retinoids in Acne Vulgaris Patients
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
Acne Vulgaris
Eligibility:
All Genders
11-35 years
Phase:
PHASE2
Brief Summary
The study was 8 weeks, randomized, double-blind, placebo-controlled trial to assess the effect of zinc sulphate on symptoms of mild and moderate acne vulgaris in 122 patients. Participants was assesse...
Detailed Description
Acne vulgaris (AV) is the eighth most prevalent disease worldwide. Acne is a self-limiting condition, it may cause significant psychological and social problems, depression, disfigurement, and scarrin...
Eligibility Criteria
Inclusion
- Newly diagnosed mild and moderate AV patients diagnosed by a dermatologist at the outpatient Department of Dermatology and Venereology,
- Age: 11-35 years,
- Gender: Both male and female
Exclusion
- Pregnancy and lactation,
- History of oral contraceptive pills, zinc, and iron intake,
- Suffering from any cosmetic induced acne
Key Trial Info
Start Date :
April 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT04899843
Start Date
April 27 2021
End Date
November 30 2021
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Basic Science and Paraclinical Science of BSMMU
Dhaka, Bangladesh